Literature DB >> 16244775

Clinico-hematologic profile of factor XIII-deficient patients.

M Bhattacharya1, A Biswas, R P H Ahmed, M Kannan, M Gupta, M Mahapatra, V P Choudhry, R Saxena.   

Abstract

A retrospective analysis of clinico-hematologic parameters of 18 factor XIII-deficient patients was carried out. The hematologic tests included activated partial thromboplastin time (APTT), prothrombin time (PT), and clot solubility. Laboratory diagnosis of FXIII deficiency was made where bleeding time, PT, APTT, and thrombin time were normal and the clot solubility test result with 5M urea was positive. Factor XIII level with family screening was performed using commercially available kits. History of prolonged bleeding from the umbilical stump was present in four (22.2%) patients. The most common site of bleeding was the skin (11 of 18 patients). Three patients were given prophylaxis (FFP in two, factor XIII in one). A high prevalence of recurrent abortion in female patients with FXIII deficiency (two of the three patients in this study) was observed.

Entities:  

Mesh:

Year:  2005        PMID: 16244775     DOI: 10.1177/107602960501100416

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  4 in total

Review 1.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

2.  Clinical profile of patients with rare inherited coagulation disorders: a retrospective analysis of 67 patients from northern India.

Authors:  Sanjeev Kumar Sharma; Suman Kumar; Tulika Seth; Pravas Mishra; Narendra Agrawal; Gurmeet Singh; Avinash Kumar Singh; Manoranjan Mahapatra; Seema Tyagi; Haraprasad Pati; Renu Saxena
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-10-02       Impact factor: 2.576

3.  New developments in the management of congenital Factor XIII deficiency.

Authors:  Zehra Fadoo; Quratulain Merchant; Karim Abdur Rehman
Journal:  J Blood Med       Date:  2013-05-28

Review 4.  Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?

Authors:  Wolfgang Korte
Journal:  J Blood Med       Date:  2014-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.